FibroBiologics is pursuing a development program for FSdC spheroids with the goal of advancing to clinical trials. The data includes comprehensive preclinical pharmacology and efficacy assessments ...

BioRestorative Therapies, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its BRTX-100 program for treating chronic lumbar disc disease (cLDD).

Backed by more than three decades of clinical evidence and innovation, the prodisc platform continues to advance total disc ...

Rochester Institute of Technology researchers are improving non-invasive treatment options for degenerative disc disease, an ailment that impacts 3 million adults yearly in the U.S., according to the ...

August 20, 2024 — Among patients undergoing lumbar spinal fusion, the presence of Modic changes is associated with differences in microbial diversity and metabolites in the lumbar cartilaginous ...

Around four years ago, Hannah Polach, 42, began experiencing numbness and tingling in her arms that would wake her from a ...

Here are 40 spine devices and technologies earning FDA clearances in 2025. Note: This is not an exhaustive list. 1. SurGenTec earned FDA 510(k) clearance for its OsteoFlo HydroFiber to be used as a ...